Evaluation of a new selective agar medium for detection of carbapenem-resistant Enterobacteriaceae.
Autor: | Kuwahara-Arai K; Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan., Morito A; Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan., Yanagisawa I; Microbiology Research Division, Kojin Bio Co., Ltd., Saitama, Japan., Hishinuma T; Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan., Mya S; National Health Laboratory, Yangon, Myanmar., Zan KN; National Health Laboratory, Yangon, Myanmar., Tohya M; Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan., Tada T; Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan., Tin HH; National Health Laboratory, Yangon, Myanmar., Sekiguchi JI; Microbiology Research Division, Kojin Bio Co., Ltd., Saitama, Japan., Watanabe S; Department of Microbiome Research, Juntendo University Graduate School of Medicine, Tokyo, Japan., Kirikae T; Department of Microbiology, Juntendo University School of Medicine, Tokyo, Japan. Electronic address: t-kirikae@juntendo.ac.jp. |
---|---|
Jazyk: | angličtina |
Zdroj: | Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2019 Dec; Vol. 95 (4), pp. 114882. Date of Electronic Publication: 2019 Aug 07. |
DOI: | 10.1016/j.diagmicrobio.2019.114882 |
Abstrakt: | CRE-JU is a novel selective agar for carbapenem-resistant Enterobacteriaceae that contains ceftazidime, cloxacillin, meropenem, and vancomycin. This study evaluated the ability of 63 carbapenem-resistant isolates and 53 non-carbapenem-resistant Enterobacteriaceae strains clinically isolated in Japan, Myanmar, Nepal, and Vietnam to grow on CRE-JU. CRE-JU showed 92.1% sensitivity and 100% specificity for detecting carbapenem-resistant Enterobacteriaceae compared with dug susceptibility profiles. (Copyright © 2019 Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |